Form 4 for ROIV Roivant Sciences Ltd.
Accepted 2024-07-25 00:00:00 ET · period of report 2024-07-23 · accession 0001140361-24-034281 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-07-25 | 2024-07-23 | ROIV | Oren Ilan | Dir | F - Tax | $11.01 | -215 | 82.6K | -0.3% | -$2,367 | |
| 2024-07-25 | 2024-07-23 | ROIV | Oren Ilan | Dir | A - Grant | $0.00 | +2,440 | 82.8K | +3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2024-07-23 | F | D | 215 | $11.01 | 82,634 | D | — | — | (F2) Represents the "net settlement" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares. |
| 2 | Common | Common Shares | 2024-07-23 | A | A | 2,440 | $0.00 | 82,849 | D | — | — | (F1) Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date. |